You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.
The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.
The grant, to support the work of the GenOMICC consortium, will help to identify genetic factors associated with response to the virus.
The firm has signed a three-year agreement with the University Hospital of Zurich to develop the test for use in kidney transplant recipients.
The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device.
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.
Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.
The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.
The planned DNA library is expected to enable the use of environmental DNA to develop accurate species lists for a given sampled area.
At the ASHG 2020 virtual meeting, researchers presented data showing they could use the method to enrich for placental DNA in maternal plasma samples.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.